Reset filter
Mots-clés
C95.9 ×
Afficher plus Mots-clés
Table des matières
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

380 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Eligibility Refractory Leukemia NCT00880269

- 25/09/2018 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Panobinostat (LBH5789) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT00880269

Eligibility Leukemia NCT01050764

- 23/05/2018 - 1 Formulaire, 1 Groupe Item, 25 Eléments de données, 1 Langue
Groupe Item: Criteria
Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204); ODM derived from: https://clinicaltrials.gov/show/NCT01050764

Eligibility Leukemia NCT01038635

- 22/05/2018 - 1 Formulaire, 2 Groupes Item, 19 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01038635

Eligibility Leukemia NCT00990249

- 22/05/2018 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT00990249

Eligibility Leukemia NCT00897182

- 19/05/2018 - 1 Formulaire, 1 Groupe Item, 11 Eléments de données, 1 Langue
Groupe Item: Criteria
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00897182

Eligibility Leukemia NCT00897078

- 19/05/2018 - 1 Formulaire, 2 Groupes Item, 22 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings; ODM derived from: https://clinicaltrials.gov/show/NCT00897078

Eligibility Leukemia NCT00891137

- 19/05/2018 - 1 Formulaire, 1 Groupe Item, 18 Eléments de données, 1 Langue
Groupe Item: Criteria
Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy; ODM derived from: https://clinicaltrials.gov/show/NCT00891137

Eligibility Leukemia NCT00882076

- 18/05/2018 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias; ODM derived from: https://clinicaltrials.gov/show/NCT00882076

Eligibility Leukemia NCT00860522

- 18/05/2018 - 1 Formulaire, 2 Groupes Item, 20 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
JVRS-100 for the Treatment of Patients With Relapsed or Refractory Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00860522

Eligibility Leukemia NCT00844441

- 18/05/2018 - 1 Formulaire, 1 Groupe Item, 21 Eléments de données, 1 Langue
Groupe Item: Criteria
Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00844441

Eligibility Leukemia NCT00800566

- 18/05/2018 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00800566

Eligibility Leukemia NCT00631059

- 17/05/2018 - 1 Formulaire, 2 Groupes Item, 21 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00631059

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial